SCIENTIFIC BACKGROUND

CASR, GCM2, GNA11, PTH

Category:

Hypoparathyroidism is characterized by reduced serum calcium and increased serum phosphate concentrations, in conjunction with reduced parathyroid hormone (PTH) secretion. This condition can be caused by damage to, or removal of, parathyroid tissue but has also been observed in various syndromic disorders.

 

Hypoparathyroidism can also occur in isolation, such as in the context of familial isolated hypoparathyroidism (FIH) or autosomal dominant hypocalcemia (ADH). In these instances, the condition is typically caused by inactivating variants in the PTH or GCM2 genes, or activating variants in the GNA11 or CASR gene, as observed in ADH patients.

 

The condition known as autosomal dominant hypocalcemia (ADH) is also characterized by consistently decreased serum calcium levels, but with normal or only slightly decreased PTH concentration. Although hypocalcemia can sometimes be asymptomatic, the clinical presentation can vary significantly and may include severe recurrent seizures. An adjustment of the calcium level in these cases can lead to increased urinary calcium excretion, potentially resulting in renal failure. Therefore, any therapeutic measures should only be undertaken with close monitoring.

 

References
Baumgartner-Parzer et al. 2018, J. Klin. Endokrinol. Stoffw. 11:51 / Cinque et al. 2017, JCEM, 102:3961 / Hendy et al. 2017, Endotext [Internet] MDText.com, Inc., South Dartmouth (MA) / Clarke et al. 2016, J Clin Endocrinol Metab 101:2284 / Hannan et al. 2016, J Mol Endocrinol 57:R127 / Tenhola et al. 2016, Eur J Endocrinol 175:211 / Kinoshita et al. 2014, J Clin Endocrinol Metab 99:E363 / Raue et al. 2011, Clin Endocrinol (Oxf) 75:760

GENES

CASR, GCM2, GNA11, PTH

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more